18F-LNC1016

N/A

Report date: 2025/09/08 17:07:56
NME

Base Information

Drug Name18F-LNC1016
Drug Alias Name18F-LNC101618F-LNC-1016
ClassificationSmall molecules > Synthetic peptideRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4] 
Mechanisms of ActionPositron-emission tomography enhancersIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesYantai Lannacheng Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYantai Lannacheng Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A